miscsubjectsAI governance
Evidence review

SS-31 (Elamipretide) for PPI Users: Mitochondrial Pathways and Drug Context

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `ss-31-ppis`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/ss-31-ppis

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-ppis/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-ppis/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-ppis/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-ppis/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have PPIs (omeprazole, etc.)

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why SS-31 (Elamipretide) might help you

  1. You are reading about PPIs (omeprazole, etc.) — what breaks down matters before any compound name.
  2. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

Why PPIs (omeprazole, etc.) matters for you

  1. Drug: PPIs (omeprazole, etc.)
  2. What it does: Acid suppression; long-term mucosal and nutrient consequences.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • SS-31 (Elamipretide) → mitochondrial

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 2
  • Claims tagged preclinical (animal/lab): 1
  • Claims tagged anecdotal: 0
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 3

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.36 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors (source s1)

Review summarizing observational links between PPIs and deficiencies.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The mitochondrially targeted peptide elamipretide (SS-31) improves ADP sensitivity in aged mitochondria (source s2)

Preclinical study on SS-31 mechanism.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

A Trial to Evaluate Safety and Efficacy of Elamipretide Primary Mitochondrial Myopathy (source s3)

Trial details confirming human study existence.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

PPIs · drug map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 3 sources · swipe →chain a6893a6ccdaf · verify chain · provenance
Evidence ledger 4 · tier-ranked · API
human
Long-term PPI use is associated with vitamin B12, magnesium, and calcium deficiencies in observational data.
sources: s1
preclinical
SS-31 binds cardiolipin in the inner mitochondrial membrane and reduces ROS in preclinical models.
sources: s2
mechanistic
No human trials examine SS-31 in PPI users.
humanlow confidence
Human trials of SS-31 exist for primary mitochondrial myopathy and heart failure with mixed primary endpoint results; recent approval for Barth syndrome.
sources: s3
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:48
SS-31 (Elamipretide) for PPI Users: Mitochondrial Pathways and Drug Context · 4 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Ss 31 for Ppis
Slug: ss-31-ppis
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_cross","condition":"PPIs (omeprazole, etc.)","condition_key":"ppis","primary_peptide":"ss-31","peptides_in_scope":[{"id":"ss-31","name":"SS-31 (Elamipretide)"}],"drugs_in_scope":["ppis"],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down if yo
it output
{
  "slug": "ss-31-ppis",
  "title": "SS-31 (Elamipretide) for PPI Users: Mitochondrial Pathways and Drug Context",
  "body": "## What's breaking down if you have PPIs (omeprazole, etc.)\n\nLong-term PPI use centers on acid suppression in the stomach. This reduces acid production but can lead to downstream effects on nutrient absorption and mucosal health. Observational data link extended use to deficiencies in vitamin B12, magnesium, and calcium. These shortfalls can impair cellular energy processes and tissue maintenance over time.\n\nMitochondria rely on adequate cofactors for ATP generation and antioxidant defense. When absorption dips, mitochondrial efficiency may decline in some contexts. One line of discussion notes that proton pumps exist in mitochondria too, raising the possibility of broader effects beyond the stomach, though this remains indirect. The net result is a potential imbalance where repair processes face extra hurdles while symptoms of reflux stay managed.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about PPIs (omeprazole, etc.) — what breaks down matters before any compound name.\n2. Therefore for you: If mitochondrial function is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 concentrates in the inner mitochondrial membrane and binds cardiolipin. This
2f141ff249fa2595
Machine verification: /api/articles/ss-31-ppis/contributions
Ask this article · 6 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Long-term PPI use is associated with vitamin B12, magnesium, and calcium deficiencies in observational data."?
ask ss-31-ppis claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "SS-31 binds cardiolipin in the inner mitochondrial membrane and reduces ROS in preclinical models."?
ask ss-31-ppis claim c2 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "No human trials examine SS-31 in PPI users."?
ask ss-31-ppis claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "Human trials of SS-31 exist for primary mitochondrial myopathy and heart failure with mixed primary endpoint results; recent approval for Ba…"?
ask ss-31-ppis claim c3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about SS-31 (Elamipretide) for PPI Users: Mitochondrial Pathways and Drug Context — and what would you need me to tell you first?
ask ss-31-ppis condition gaps · paste includes §SELF
What good and bad outcomes are documented for SS-31 (Elamipretide) for PPI Users: Mitochondrial Pathways and Drug Context (studies vs anecdotes)?
ask ss-31-ppis good bad experiences · paste includes §SELF
ss-31-ppis · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 19371 tokens · $0 · 2 models
chain head 0275d2aef89b41a0
write grok/grok-4.3 · 2026-06-29 23:48 · 19371 tok · 7b274414ae88
voxel_divide owner · 2026-07-17 02:42 · tokens unrecorded · 0275d2aef89b
verify chain →
Live ledger · 29 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 19:43
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 17:32
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 12:01
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 08:36
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 08:05
JCI_TRAFFIC jci · HTTP 200 · 2026-07-27 05:39
view full ledger & cards →
REST + ledger
read GET /api/articles/ss-31-ppis · GET /api/articles/ss-31-ppis?format=post (the editable body)
create/replace POST /api/articles/ss-31-ppis · PUT /api/articles/ss-31-ppis (replace, keeps revision) · PATCH /api/articles/ss-31-ppis (merge)
delete DELETE /api/articles/ss-31-ppis
writes need header x-terminal-key
LLM bundle GET /api/articles/ss-31-ppis/bundle?format=markdown — body + claims + sources + provenance + manifest
post claim POST /api/protocol/claim · iMessage claim ss-31-ppis|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →